Infinity Pharmaceuticals Begins Enrolling for Pancreatic Cancer Drug Trial

February 25, 2011
Infinity Pharmaceuticals Inc. of Cambridge is moving forward with the first drug candidate stemming from its $75 million alliance with Purdue Pharmaceutical Products LP of Stamford, Conn., and Mundipharma International Corporation Ltd. of the UK.
Mass High Tech